Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
BIOG_p | Xetra | EUR | Delayed | |
BIOG | Xetra | EUR | Delayed | |
BIO3d | BATS Europe | EUR | Delayed | |
BIOG | Frankfurt | EUR | Delayed | |
BIOG | TradeGate | EUR | Delayed | |
BIOG_p | TradeGate | EUR | Delayed | |
BIOG_p | Frankfurt | EUR | Delayed | |
BIO3 | Vienna | EUR | Real-time |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Revenue | 184.3 | 252.8 | 130.3 | 117.2 |
Gross Profit | 69.1 | 166.4 | 20.1 | 24.7 |
Operating Income | -8.8 | 133.3 | 1.3 | -9.1 |
Net Income | 38.6 | 114.4 | -5.6 | -20.4 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Assets | 1410.9 | 1349.5 | 1214.1 | 1190.2 |
Total Liabilities | 912 | 889.6 | 840.6 | 839.1 |
Total Equity | 498.9 | 459.9 | 373.5 | 351.1 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 66.3 | 5.8 | -37.5 | -37.3 |
Cash From Investing Activities | -12.1 | -6 | 29.6 | -10.2 |
Cash From Financing Activities | -11.6 | 7.3 | -1.2 | -1.3 |
Net Change in Cash | 42.7 | 7.1 | -9.7 | -48.6 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review